Henschke N., Kamper SJ., Maher C.G. The epidemiology and economic consequences of pain. Mayo Clin Proc. 2015;90(1):139-147. https://doi.org/10.1016/j.mayocp.2014.09.010..
DOI: 10.1016/j.mayocp.2014.09.010
Hasselstrom J., Liu-Palmgren J., Rasjo-Wraak G. Prevalence of pain in general practice. Eur J Pain. 2002;6(5):375-385. https://doi.org/10.1016/s1090-3801(02)00025-3..
DOI: 10.1016/s1090-3801(02)00025-3
Gregory J., McGowan L. An examination of the prevalence of acute pain for hospitalised adult patients: a systematic review. J Clin Nurs. 2016;25(5-6):583-598. https://doi.org/10.1111/jocn.13094..
DOI: 10.1111/jocn.13094
Kent M.L., Tighe PJ., Belfer I., Brennan TJ., Bruehl S., Brummett C.M. et al. The ACTTION-APS-AAPM Pain Taxonomy (AAAPT) multidimensional approach to classifying acute pain conditions. Pain Med. 2017;18(5):947-958. https://doi.org/10.1093/pm/pnx019..
DOI: 10.1093/pm/pnx019
McOuay HJ.K.E., Moore R.A. (eds.). Epidemiology of chronic pain. Seattle: I ASP Press; 2008.
Andersson H.I., Ejlertsson G., Leden I., Schersten B. Impact of chronic pain on health care seeking, self care, and medication. Results from a population-based Swedish study. J Epidemiol Community Health. 1999;53(8):503-509. https://doi.org/10.1136/jech.53.8.503..
DOI: 10.1136/jech.53.8.503
Eriksen J., Sjogren P, Ekholm O., Rasmussen N.K. Health care utilisation among individuals reporting long-term pain: an epidemiological study based on Danish National Health Surveys. Eur J Pain. 2004;8(6):517-523. https://doi.org/10.1016/j.ejpain.2003.12.001..
DOI: 10.1016/j.ejpain.2003.12.001
Cordell W.H., Keene K.K., Giles B.K., Jones J.B., Jones J.H., Brizendine EJ. The high prevalence of pain in emergency medical care. Am J Emerg Med. 2002;20(3):165-169. https://doi.org/10.1053/ajem.2002.32643..
DOI: 10.1053/ajem.2002.32643
Tracey I., Bushnell M.C. How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain. 2009;10(11):1113-1120. https://doi.org/10.1016/j.jpain.2009.09.001..
DOI: 10.1016/j.jpain.2009.09.001
Young Casey C., Greenberg M.A., Nicassio P.M., Harpin R.E., Hubbard D. Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors. Pain. 2008;134(1-2):69-79. https://doi.org/10.1016/j.pain.2007.03.032..
DOI: 10.1016/j.pain.2007.03.032
Voscopoulos C., Lema M. When does acute pain become chronic? Br J Anaesth. 2010;105(1 Suppl.):i69-i85. https://doi.org/10.1093/bja/aeq323..
DOI: 10.1093/bja/aeq323
Ung H., Brown J.E., Johnson K.A., Younger J., Hush J., Mackey S. Multivariate classification of structural MRI data detects chronic low back pain. Cereb Cortex. 2014;24(4):1037-1044. https://doi.org/10.1093/cercor/bhs378..
DOI: 10.1093/cercor/bhs378
May A. Chronic pain may change the structure of the brain. Pain. 2008;137(1):7-15. https://doi.org/10.1016/j.pain.2008.02.034..
DOI: 10.1016/j.pain.2008.02.034
Machelska H., Schopohl J.K., Mousa S.A., Labuz D., Schaefer M., Stein C. Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol. 2003;141(1-2):30-39. https://doi.org/10.1016/s0165-5728(03)00213-3..
DOI: 10.1016/s0165-5728(03)00213-3
Castellheim A., Brekke O.L., Espevik T., Harboe M., Mollnes T.E. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scand J Immunol. 2009;69(6):479-491. https://doi.org/10.1111/j.1365-3083.2009.02255.x..
DOI: 10.1111/j.1365-3083.2009.02255.x
Fusco M., Skaper S.D., Coaccioli S., Paladini A., Varrassi G. Degenerative joint diseases and neuroinflammation. Pain Pract. 2017;17(4):522-532. https://doi.org/10.1111/papr.12551..
DOI: 10.1111/papr.12551
Nathan C., Ding A. Nonresolving inflammation. Cell. 2010;140(6):871-882. https://doi.org/10.1016/j.cell.2010.02.029..
DOI: 10.1016/j.cell.2010.02.029
Nathan C., Ding A. Nonresolving inflammation. Cell. 2010;140(6):871-882. https://doi.org/10.1016/j.cell.2010.02.029..
DOI: 10.1016/j.ceLL.2010.02.029
Varrassi G., Fusco M., Coaccioli S., Paladini A. Chronic pain and neurodegenerative processes in elderly people. Pain Pract. 2015;15(1):1-3. https://doi.org/10.1111/papr.12254..
DOI: 10.1111/papr.12254
Myers R.R., Campana W.M., Shubayev V.I. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today. 2006;11(1-2):8-20. https://doi.org/10.1016/S1359-6446(05)03637-8..
DOI: 10.1016/S1359-6446(05)03637-8
Vanegas H., Schaible H.G. Prostaglandins and cyclooxygenases [correction of cyclooxygenases] in the spinal cord. Prog Neurobiol. 2001;64(4):327-363. https://doi.org/10.1016/s0301-0082(00)00063-0..
DOI: 10.1016/s0301-0082(00)00063-0
Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., Ersparmer V. The tachykinin peptide family. Pharmacol Rev. 2002;54(2):285-322. https://doi.org/10.1124/pr.54.2.285..
DOI: 10.1124/pr.54.2.285
Rosa A.C., Fantozzi R. The role of histamine in neurogenic inflammation. Br J Pharmacol. 2013;170(1):38-45. https://doi.org/10.1111/bph.12266..
DOI: 10.1111/bph.12266
Birklein F., Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett. 2008;437(3):199-202. https://doi.org/10.1016/j.neulet.2008.03.081..
DOI: 10.1016/j.neulet.2008.03.081
Birklein F., Schmelz M. Neuropeptides, neurogenic inflammation and complex regional pain syndrome (CRPS). Neurosci Lett. 2008;437(3):199-202. https://doi.org/10.1016/j.neulet.2008.03.081..
DOI: 10.1016/j.neuLet.2008.03.081
Walker A.K., Kavelaars A., Heijnen CJ., Dantzer R. Neuroinflammation and comorbidity of pain and depression. Pharmacol Rev. 2013;66(1):80-101. https://doi.org/10.1124/pr.113.008144..
DOI: 10.1124/pr.113.008144
Ji R.R., Berta T., Nedergaard M. Glia and pain: is chronic pain a gliopathy? Pain. 2013;154 Suppl. 1(01):s10-s28. https://doi.org/10.1016/j.pain.2013.06.022..
DOI: 10.1016/j.pain.2013.06.022
Воробьева О.В. Хроническая боль в спине: от патогенетических концепций к терапевтическим стратегиям. Медицинский совет. 2017;(17):36-42. https://doi.org/10.21518/2079-701X-2017-17-36-42..
DOI: 10.21518/2079-701X-2017-17-36-42
Давыдов О.С. Периферические и центральные механизмы перехода острой боли в хроническую и возможная роль ингибирования циклооксигеназы 2 в предотвращении хронизации болевого синдрома. Неврология, нейропсихиатрия, психосоматика. 2016;8(2):10-16. http://dx.doi.org/10.14412/2074-2711-2016-2-10-16..
DOI: 10.14412/2074-2711-2016-2-10-16
Koes B.W., van Tulder M.W., Thomas S. Diagnosis and treatment of low back pain. BMJ. 2006;332(7555):1430-1434. https://doi.org/10.1136/bmj.332.7555.1430..
DOI: 10.1136/bmj.332.7555.1430
Jensen M.C., Brant-Zawadzki M.N., Obuchowski N., Modic MT., Malkasian D., Ross J.S. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994;331(2):69-73. https://doi.org/10.1056/NEJM199407143310201..
DOI: 10.1056/NEJM199407143310201
Weinreb J.C., Wolbarsht L.B., Cohen J.M., Brown C.E., Maravilla K.R. Prevalence of lumbosacral intervertebral disk abnormalities on MR images in pregnant and asymptomatic nonpregnant women. Radiology. 1989;170(1 Pt. 1): 125-128. https://doi.org/10.1148/radiology.170.1.2521192..
DOI: 10.1148/radiology.170.1.2521192
Weinreb J.C., Wolbarsht L.B., Cohen J.M., Brown C.E., Maravilla K.R. Prevalence of lumbosacral intervertebral disk abnormalities on MR images in pregnant and asymptomatic nonpregnant women. Radiology. 1989;170(1 Pt. 1): 125-128. https://doi.org/10.1148/radiology.170.1.2521192..
DOI: 10.1148/radioLogy.170.1.2521192
Haldeman S. North American Spine Society: failure of the pathology model to predict back pain. Spine (Phila Pa 1976). 1990;15(7):718-724. https://pubmed.ncbi.nlm.nih.gov/2145646/https://pubmed.ncbi.nlm.nih.gov/2145646/
Haldeman S. North American Spine Society: failure of the pathology model to predict back pain. Spine (Phila Pa 1976). 1990;15(7):718-724. https://pubmed.ncbi.nlm.nih.gov/2145646/https://pubmed.ncbi.nLm.nih.gov/2145646/
Huang Z.Y., Xu H.C., Lei T., Li Q.L., Wu A.M., Ni W.F. The location of Modic changes in the lumbar spine: a meta-analysis. Eur Spine J. 2016;25(11):3746-3759. https://doi.org/10.1007/s00586-016-4456-x..
DOI: 10.1007/s00586-016-4456-x
Nguyen C., Jousse M., Poiraudeau S., Feydy A., Rannou F. Intervertebral disc and vertebral endplate subchondral changes associated with Modic 1 changes of the lumbar spine: a cross-sectional study. BMC Musculoskelet Disord. 2017;18(1):34. https://doi.org/10.1186/s12891-017-1407-6..
DOI: 10.1186/s12891-017-1407-6
Johnson Z.I., Schoepflin Z.R., Choi H., Shapiro I.M., Risbud M.V. Disc in flames: Roles of TNF-a and IL-1p in intervertebral disc degeneration. Eur Cell Mater. 2015;30:104-116. https://doi.org/10.22203/ecm.v030a08..
DOI: 10.22203/ecm.v030a08
Anderson D.G., Tannoury C. Molecular pathogenic factors in symptomatic disc degeneration. Spine J. 2005;5(6S):S260-S266. https://doi.org/10.1016/j.spinee.2005.02.010..
DOI: 10.1016/j.spinee.2005.02.010
Navone S.E., Marfia G., Canzi L., Ciusani E., Canazza A., Visintini S. et al. Expression of neural and neurotrophic markers in nucleus pulposus cells isolated from degenerated intervertebral disc. J Orthop Res. 2012;30(9):1470-1477. https://doi.org/10.1002/jor.22098..
DOI: 10.1002/jor.22098
Зайцева E.M., Алексеева Л.И., Насонов Е.Л. Патогенез остеоартроза и обоснование применения стронция ранелата. Научно-практическая ревматология. 2013;51(6):696-702. https://doi.org/10.14412/1995-4484-2013-696-702..
DOI: 10.14412/1995-4484-2013-696-702
Barr AJ., Campbell T.M., Hopkinson D., Kingbury S.R., Bowes M.A., Conaghan P.G. A systematic review of the relationship between subchondral bone features, pain and structural pathology in peripheral joint osteoarthritis. Arthritis Res Ther. 2015;17(1):228. https://doi.org/10.1186/s13075-015-0735-x..
DOI: 10.1186/s13075-015-0735-x
Farrell M., Gibson S., McMeeken J., Helme R. Pain and hyperalgesia in osteoarthritis of the hands. J Rheumatol. 2000;27(2):441-447. Available at: https://pubmed.ncbi.nlm.nih.gov/10685812/https://pubmed.ncbi.nlm.nih.gov/10685812/
Farrell M., Gibson S., McMeeken J., Helme R. Pain and hyperalgesia in osteoarthritis of the hands. J Rheumatol. 2000;27(2):441-447. Available at: https://pubmed.ncbi.nlm.nih.gov/10685812/https://pubmed.ncbi.nLm.nih.gov/10685812/
Nieminen L.K., Pyysalo L.M., Kankaanpaa MJ. Prognostic factors for pain chronicity in low back pain: a systematic review. Pain Rep. 2021;6(1):e919. https://doi.org/10.1097/PR9.0000000000000919..
DOI: 10.1097/PR9.0000000000000919
Webb R., Brammah T., Lunt M., Urwin M., Allison T., Symmons D. Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population. Spine (Phila Pa 1976). 2003;28(11):1195-1202. https://doi.org/10.1097/01.BRS.0000067430.49169.01..
DOI: 10.1097/01.BRS.0000067430.49169.01
Thorbjornsson C.B., Alfredsson L., Fredriksson K., Michelsen H., Punnett L., Vingard E. et al. Physical and psychosocial factors related to low back pain during a 24-year period. A nested case-control analysis. Spine (Phila Pa 1976). 2000;25(3):369-374. https://doi.org/10.1097/00007632-200002010-00019..
DOI: 10.1097/00007632-200002010-00019
Crissey J.M., Jenkins N.T., Lansford K.A., Thorne P.K., Bayless D.S., Vieira-Potter VJ. Adipose tissue and vascular phenotypic modulation by voluntary physical activity and dietary restriction in obese insulin-resistant OLETF rats. Am J Physiol Regul Integr Comp Physiol. 2014;306(8):R596-606. https://doi.org/10.1152/ajpregu.00493.2013..
DOI: 10.1152/ajpregu.00493.2013
Han J.M., Levings M.K. Immune regulation in obesity-associated adipose inflammation. J Immunol. 2013;191(2):527-532. https://doi.org/10.4049/jimmunol.1301035..
DOI: 10.4049/jimmunol.1301035
Han J.M., Levings M.K. Immune regulation in obesity-associated adipose inflammation. J Immunol. 2013;191(2):527-532. https://doi.org/10.4049/jimmunol.1301035..
DOI: 10.4049/jimmunoL.1301035
Ronti T., Lupattelli G., Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006;64(6):355-365. https://doi.org/10.1111/j.1365-2265.2006.02474.x..
DOI: 10.1111/j.1365-2265.2006.02474.x
Zhang J.M., An J. Cytokines, inflammation and pain. Int Anesthesiol Clin. 2007;45(2):27-37. https://doi.org/10.1097/AIA.0b013e318034194e..
DOI: 10.1097/AIA.0b013e318034194e
Vuolteenaho K., Koskinen A., Moilanen E. Leptin - a link between obesity and osteoarthritis. Applications for prevention and treatment. Basic Clin Pharmacol Toxicol. 2014;114(1):103-108. https://doi.org/10.1111/bcpt.12160..
DOI: 10.1111/bcpt.12160
Andersen L.L., Clausen T., Persson R., Holtermann A. Perceived physical exertion during healthcare work and risk of chronic pain in different body regions: prospective cohort study. Int Arch Occup Environ Health. 2013;86(6):681-687. https://doi.org/10.1007/s00420-012-0808-y..
DOI: 10.1007/s00420-012-0808-y
Heneweer H., Aufdemkampe G., van Tulder M.W., Kiers H., Stappaerts K.H., Vanhees L. Psychosocial variables in patients with (sub)acute low back pain: an inception cohort in primary care physical therapy in the Netherlands. Spine (Phila Pa 1976). 2007;32(5):586-592. https://doi.org/10.1097/01.brs.0000256447.72623.56..
DOI: 10.1097/01.brs.0000256447.72623.56
Henschke N., Maher C.G., Refshauge K.M., Herbert R.D., Cumming R.G., Bleasel J. et al. Prognosis in patients with recent onset low back pain in Australian primary care: inception cohort study. BMJ. 2008;337(7662):a171. https://doi.org/10.1136/bmj.a171..
DOI: 10.1136/bmj.a171
Smedley J., Inskip H., Cooper C., Coggon D. Natural history of low back pain. A longitudinal study in nurses. Spine (Phila Pa 1976). 1998;23(22):2422-2426. https://doi.org/10.1097/00007632-199811150-00012..
DOI: 10.1097/00007632-199811150-00012
Wand B.M., McAuley J.H., Marston L., De Souza L.H. Predicting outcome in acute low back pain using different models of patient profiling. Spine (Phila Pa 1976). 2009;34(18):1970-1975. https://doi.org/10.1097/BRS.0b013e3181afeab7..
DOI: 10.1097/BRS.0b013e3181afeab7
Oliveira C.B., Maher C.G., Pinto R.Z., Traeger A.C., Lin C.C., Chenot J.F. et al. Clinical practice guidelines for the management of nonspecific low back pain in primary care: an updated overview. Eur Spine J. 2018;27(11):2791-2803. https://doi.org/10.1007/s00586-018-5673-2..
DOI: 10.1007/s00586-018-5673-2
da Costa B.R., Reichenbach S., Keller N., Nartey L., Wandel S., Juni P., Trelle S. Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network metaanalysis. Lancet. 2017;390(10090):e21-e33. https://doi.org/10.1016/S0140-6736(17)31744-0..
DOI: 10.1016/S0140-6736(17)31744-0
Roberts E., Delgado Nunes V., Buckner S., Latchem S., Constanti M., Miller P. et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552-559. https://doi.org/10.1136/annrheumdis-2014-206914..
DOI: 10.1136/annrheumdis-2014-206914
Каратеев А.Е. Нимесулид в российской клинической практике: старый друг лучше новых двух. Медицинский совет. 2014;(5):82-91. Режим доступа: https://www.med-sovet.pro/jour/article/view/573.https://www.med-sovet.pro/jour/article/view/573
Каратеев А.Е. Нимесулид в российской клинической практике: старый друг лучше новых двух. Медицинский совет. 2014;(5):82-91. Режим доступа: https://www.med-sovet.pro/jour/article/view/573.https://www.med-sovet.pro/jour/articLe/view/573
Dallegri F., Ottonello L. Are there any Differences among Non-Steroidal Anti-Inflammatory Drugs? Focus on Nimesulide. Clin Drug Invest. 2007;27(1 Suppl.):15-22. https://doi.org/10.2165/00044011-200727001-00004..
DOI: 10.2165/00044011-200727001-00004
Bjarnason I., Thjodleifsson B. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology (Oxford). 1999;38(1 Suppl.):24-32. https://doi.org/10.1093/rheumatology/38.suppl_1.24..
DOI: 10.1093/rheumatology/38.suppl_1.24
Bjarnason I., Thjodleifsson B. Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology (Oxford). 1999;38(1 Suppl.):24-32. https://doi.org/10.1093/rheumatology/38.suppl_1.24..
DOI: 10.1093/rheumatoLogy/38.suppL_1.24
Gupta P, Sachdev H.P. Safety of oral use of nimesulide in children: systematic review of randomized controlled trials. Indian Pediatr. 2003;40(6):518-531. Available at: http://www.indianpediatrics.net/june2003/june-518-531.htm.http://www.indianpediatrics.net/june2003/june-518-531.htm
Gupta P, Sachdev H.P. Safety of oral use of nimesulide in children: systematic review of randomized controlled trials. Indian Pediatr. 2003;40(6):518-531. Available at: http://www.indianpediatrics.net/june2003/june-518-531.htm.http://www.indianpediatrics.net/june2003/june-518-531.htm
Kowalski M.L., Makowska J. Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity: safety of cyclo-oxygenase-2 inhibitors. Treat Respir Med. 2006;5(6):399-406. https://doi.org/10.2165/00151829-200605060-00005..
DOI: 10.2165/00151829-200605060-00005
Rainsford K.D. An analysis from clinico-epidemiological data of the principal adverse events from the COX-2 selective NSAID, nimesulide, with particular reference to hepatic injury. Inflammopharmacology. 1998;6(3):203-221. https://doi.org/10.1007/s10787-998-0020-6..
DOI: 10.1007/s10787-998-0020-6
Traversa G., Bianchi C., Da Cas R., Abraha I., Menniti-Ippolito F., Venegoni M. Cohort study of hepatotoxicity associated with nimesulide and other nonsteroidal anti-inflammatory drugs. BMJ. 2003;327(7405):18-22. https://doi.org/10.1136/bmj.327.7405.18..
DOI: 10.1136/bmj.327.7405.18
Bernareggi A. Clinical pharmacokinetics and metabolism of nimesulide. Inflammopharmacology. 2001;9:81-89. https://doi.org/10.1163/156856001300248353..
DOI: 10.1163/156856001300248353